These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38707131)

  • 21. Acarbose improves glycemic control as add-on or monotherapy in Indian type-2 diabetes: Findings from the GlucoVIP multinational observational study.
    Philip E; Sundaram ML; Das R; Chauhan SK; Deshpande S; Ambhore S; Rathod R; Manjrekar P
    Indian J Endocrinol Metab; 2013 Dec; 17(Suppl 3):S674-9. PubMed ID: 24910836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fixed-Dose Combination of Dapagliflozin + Sitagliptin + Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual Combinations.
    Sahay RK; Giri R; Shembalkar JV; Gupta SK; Mohan B; Kurmi P; Kumar SR; Sawardekar VM; Mishra A; Murthy LS; Arya VV; Sonawane AR; Soni PN; Gofne SK; Karnawat SR; Rajurkar MN; Patel PM; Lakhwani LK; Mehta SC; Joglekar SJ
    Adv Ther; 2023 Jul; 40(7):3227-3246. PubMed ID: 37258803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short Term Efficacy and Safety of Insulin Glargine in Type 2 Diabetes Inadequately Controlled with Single or Two Oral Agents: A Prospective, Open Label Study.
    Aggarwal A; Wadhwa R
    J Clin Diagn Res; 2017 Jul; 11(7):OC21-OC24. PubMed ID: 28892956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Observational, Multicenter, Retrospective, Study on the Usage Patterns of the Fixed Dose Combination of Glimepiride, Metformin, and Voglibose in Type 2 Diabetes Management.
    Shamanna P; Jha PK; Makwana A; Shukla H; Bavishi C
    Cureus; 2024 Jan; 16(1):e52064. PubMed ID: 38348001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of voglibose in comparison with acarbose in type 2 diabetic patients.
    Vichayanrat A; Ploybutr S; Tunlakit M; Watanakejorn P
    Diabetes Res Clin Pract; 2002 Feb; 55(2):99-103. PubMed ID: 11796175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of postprandial blood glucose response to biphasic insulin analogue therapy.
    Borzì V; Benroubi M; Gumprecht J; Kawamori R; Ligthelm R; Shaban J; Shah S; Shestakova M; Wenying Y; Valensi P;
    Prim Care Diabetes; 2013 Apr; 7(1):63-7. PubMed ID: 23182405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of elevated liver enzymes and its relationship with type 2 diabetes mellitus in North Indian adults.
    Alam S; Raghav A; Reyaz A; Ahsan A; Ahirwar AK; Jain V; Agarwal S; Tripathi P
    Metabol Open; 2021 Dec; 12():100130. PubMed ID: 34622192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus.
    Ved P; Shah S
    Indian J Endocrinol Metab; 2012 Mar; 16 Suppl 1(Suppl1):S110-3. PubMed ID: 22701828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy.
    Malone JK; Kerr LF; Campaigne BN; Sachson RA; Holcombe JH;
    Clin Ther; 2004 Dec; 26(12):2034-44. PubMed ID: 15823767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and safety of fixed dose combination of acarbose/metformin in Indian Type 2 diabetes patients: Results from observational GLOBE Study.
    Saboo B; Reddy GC; Juneja S; Kedia AK; Manjrekar P; Rathod R;
    Indian J Endocrinol Metab; 2015; 19(1):129-35. PubMed ID: 25593840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence to Treatment and Glycemic Control in Patients with Type 2 Diabetes Mellitus: A 4-Year Follow-up PTM Bogor Cohort Study, Indonesia.
    Kaaffah S; Soewondo P; Riyadina W; Renaldi FS; Sauriasari R
    Patient Prefer Adherence; 2021; 15():2467-2477. PubMed ID: 34803376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study.
    Jin Y; Sun X; Zhao X; Zhu T
    Diabetes Ther; 2017 Jun; 8(3):611-621. PubMed ID: 28349442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lixisenatide treatment for older patients with type 2 diabetes mellitus uncontrolled on oral antidiabetics: meta-analysis of five randomized controlled trials.
    Hanefeld M; Berria R; Lin J; Aronson R; Darmon P; Evans M; Van Gaal L
    Adv Ther; 2014 Aug; 31(8):861-72. PubMed ID: 25143188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND).
    Tajima A; Tobe K; Eiki JI; Origasa H; Watada H; Shimomura I; Tokita S; Kadowaki T
    BMJ Open Diabetes Res Care; 2022 Dec; 10(6):. PubMed ID: 36585033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of newly diagnosed non-insulin-dependent diabetes mellitus in the primary care setting: effects of 2 years of gliclazide treatment--the Diadem Study.
    Cathelineau G; de Champvallins M; Bouallouche A; Lesobre B
    Metabolism; 1997 Dec; 46(12 Suppl 1):31-4. PubMed ID: 9439556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of pioglitazone in type 2 diabetes mellitus: a postmarketing observational study.
    Nafrialdi
    Acta Med Indones; 2012 Jan; 44(1):28-34. PubMed ID: 22451182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of Triglyceride Glucose Index in Type 2 Diabetes Mellitus Patients With and Without Cardiac Autonomic Neuropathy.
    Jeyaseeli A; R G; Mathivanan D; Prabagaran A
    Cureus; 2023 Jul; 15(7):e42541. PubMed ID: 37533622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GLP1 Receptor Agonist and SGLT2 Inhibitor Combination: An Effective Approach in Real-world Clinical Practice.
    Díaz-Trastoy O; Villar-Taibo R; Sifontes-Dubón M; Mozo-Peñalver H; Bernabeu-Morón I; Cabezas-Agrícola JM; Muñoz-Leira V; Peinó-García R; Martís-Sueiro A; García-López JM; Martínez-Olmos MA
    Clin Ther; 2020 Feb; 42(2):e1-e12. PubMed ID: 32005534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of Medical Nutritional Therapy in the Management of Type 2 Diabetes Mellitus.
    Varadaraj G; Sangeetha B; Nithiya DR; Dixit PK
    J Assoc Physicians India; 2021 Apr; 69(4):11-12. PubMed ID: 34470186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.